C
Orogen Royalties Inc. OGN.V
TSX
Recommendation
Prev Close
$2.43
Volume
--
Avg Vol (90D)
52,576
Market Cap
$103.45M
Dividend & Yield
$1.63(67.08%)
52-Week Range
$1.48 - $8.60
P/E (TTM)
55.61
EPS (TTM)
$0.04
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
High-Yield Healthcare: 3 Stocks With Strong Dividends
2/16/2025 - MarketBeat
3 Value Stocks with Questionable Fundamentals
12/5/2025 - StockStory Articles
Organon & Co at Piper Sandler Healthcare Conference Transcript
12/4/2025 - GuruFocus
Can Organon (OGN) Turn Rising Investor Attention Into a Durable Reboot of Its Core Story?
12/4/2025 - Simply Wall St
3 Cash-Producing Stocks We Find Risky
12/4/2025 - StockStory Articles
Organon & Co. (OGN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
12/3/2025 - Seeking Alpha: Transcripts
Organon & Co. (OGN) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript
12/3/2025 - SeekingAlpha
Russell Investments Group Ltd. Has $15.96 Million Stock Position in Organon & Co. $OGN
12/2/2025 - MarketBeat
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
12/1/2025 - Zacks Investment Research
Grantham Mayo Van Otterloo & Co. LLC Buys 108,429 Shares of Organon & Co. $OGN
12/1/2025 - MarketBeat
Organon (OGN): Buy, Sell, or Hold Post Q3 Earnings?
12/1/2025 - StockStory Articles
Organon (OGN): Exploring Valuation Following FDA Approval of First US Pertuzumab Biosimilar
11/29/2025 - Simply Wall St
Organon & Co. $OGN Shares Sold by Envestnet Asset Management Inc.
11/29/2025 - MarketBeat
Creative Planning Buys 97,429 Shares of Organon & Co. $OGN
11/28/2025 - MarketBeat
Advisors Asset Management Inc. Sells 64,625 Shares of Organon & Co. $OGN
11/28/2025 - MarketBeat
Q3 Rundown: Organon (NYSE:OGN) Vs Other Branded Pharmaceuticals Stocks
11/26/2025 - StockStory Articles
Organon To Present at the Piper Sandler 37th Annual Healthcare Conference
11/25/2025 - GuruFocus
Organon To Present at the Piper Sandler 37th Annual Healthcare Conference
11/25/2025 - Business Wire
Video: Monday's ETF with Unusual Volume: IHE
11/24/2025 - Market News Video
Can OGN's First US Biosimilar Approval Redefine Its Long-Term Oncology Strategy?
11/24/2025 - Simply Wall St
Organon & Co. (NYSE:OGN) Receives Consensus Rating of "Hold" from Brokerages
11/23/2025 - MarketBeat
Private Management Group Inc. Raises Holdings in Organon & Co. $OGN
11/23/2025 - MarketBeat
Kingsview Wealth Management LLC Acquires New Position in Organon & Co. $OGN
11/23/2025 - MarketBeat
130,136 Shares in Organon & Co. $OGN Acquired by Neo Ivy Capital Management
11/22/2025 - MarketBeat
Organon (OGN): Evaluating Value After First FDA Approval for PERJETA Biosimilar Expands Oncology Pipeline
11/19/2025 - Simply Wall St
Income Statement
Total Revenue (TTM)
$6.34M
EBITDA (TTM)
$2.83M
EBIT (TTM)
$2.69M
Net Income (TTM)
$2.95M
Balance Sheet
Total Assets (Q)
$20.49M
Total Debt (Q)
$147.40K
Total Liabilities (Q)
$1.43M
Book Value Per Share (Q)
$0.3212
Cash Flow
Cash from Operations (TTM)
$1.87M
Cash from Investing (TTM)
-$699.60K
Cash from Financing (TTM)
-$5.31M
Net Change in Cash (TTM)
-$3.60M
Filings
Filing Date
Tuesday, November 25, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
End of April (est)
Price History
Loading...
Beta
0.73
7-Day Total Return
-4.68%
30-Day Total Return
1.82%
60-Day Total Return
-1.75%
90-Day Total Return
30.23%
Year to Date Total Return
-339.04%
1-Year Total Return
-342.55%
2-Year Total Return
-87.78%
3-Year Total Return
149.73%
5-Year Total Return
502.12%
52-week Low
Jul 14, 2025 - $1.48
52-week High
Jul 04, 2025 - $8.60
Valuation
Market Cap
$103.45M - Micro Cap
Enterprise Value
$89.02M
Price/Sales (TTM)
20.52
Price/Book (Q)
7.57
Dividends and Shares
Shares Outstanding
53.55
Dividend Per Share (Most Recent)
$1.63
Dividend Per Share (TTM)
$1.63
Corporate Info
Website
www.orogenroyalties.com
Phone Number
604 248 8648
Address
1015-789 West Pender Street
Vancouver, BC V6C 1H2
Country
Canada
Year Founded
2005
Business Description
Sector
Materials
Industry
Materials
Orogen Royalties Inc. operates as a royalty and mineral exploration company in Canada, the United States, Mexico, Argentina, Kenya, and Colombia. The company operates in two segments: Mineral... more